Presently, DFS mediated FoxM1 degradation by activating lysosomal-mediated degradation, which reduced the viability of colon cancer cells in culture (Fig. 2) and in vivo in a mouse xenograft model (Fig. 6). This evidence concerns the gene FOXM1 and colonic neoplasm.